Ann-Kathrin Harsch

Ann-Kathrin Harsch

Auto-generated profile, based on publicly available information

Ann-Kathrin Harsch

Department of Research Methodology and Data Analysis in Biomechanics, Institute of Human Movement Science and Health, Chemnitz University of Technology, Chemnitz, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TMTobias A Mayer
Tobias A Mayer
DKDaniel Koska
Daniel Koska
AHAnn-Kathrin Harsch
Ann-Kathrin Harsch
CMChristian Maiwald
Christian Maiwald
Background: Disorders of the patella are among the most prevalent knee injuries. While exercise therapy is widely accepted as an effective treatment strategy, the positive effects of conventional exercise therapy under the guidance of a physiotherapist may be offset by inherent limitations, such as difficulties in scheduling appointments or statutory policies restricting the number of training sessions. Home-based exercise interventions using digital health applications (DHAs) may help address some of these limitations. Objective: This study aimed to assess the efficacy of a 12-week exercise intervention using a web-based DHA for improving knee function and reducing pain in patients with disorders of the patella (International Classification of Diseases code M22). Methods: The outcomes of the DHA intervention group (IG) were compared to a control group (CG) that received conventional physiotherapy covered by statutory health insurance in Germany (SHI-PT). A total of 259 patients with diagnosed disorders of the patella were included in the trial and randomly allocated to IG DHA (n=136, 52.5%) and CG SHI-PT (n=123, 47.5%). Two primary end points were examined: “knee function” (Knee Injury and Osteoarthritis Outcome Score—Activities of Daily Living [KOOSADL] subscale, range 0-100 points) and “knee pain” (visual analog scale [VAS], range 0-100 points). Participants were asked to complete 2 surveys: one before the first therapy session (PRE) and one after completing the treatment period of 12 weeks (POST). Results: Training with the DHA resulted in a 4.5-fold greater improvement in “knee function” (PRE–POST differences in KOOSADL score; IG DHA: 15.7 points, 95% CI 13.7-17.6 vs CG SHI-PT: 3.5 points, 95% CI 1.5-5.5) and a 3.5-fold greater reduction in “knee pain” (PRE–POST differences in VAS pain score; IG DHA: –22.5 points, 95% CI –25.2 to –19.9 vs CG SHI-PT: –6.5 points, 95% CI –8.7 to –4.4) compared to SHI-PT. The improvements in IG DHA exceeded the limits of clinical relevance. The differences between the treatment groups (KOOSADL score –10.1 points, 95% CI –infinity to -8.0; VAS pain score 14.3 points 95% CI 11.7-infinity) were statistically significant (P<.001) for both end points in favor of IG DHA. No effect was found for age or sex. The reported use of pain medication decreased substantially in IG DHA, and showed almost no change in CG SHI-PT. Conclusions: Our findings indicated that the investigated DHA is superior to SHI-PT for treating disorders of the patella. Therefore, DHA has been approved by the German Federal Institute for Drugs and Medical Devices for treating disorders of the patella in persons of all sexes aged ≥12 years. Trial Registration: German Clinical Trials Register (DRKS) DRKS00023454; https://drks.de/search/en/trial/DRKS00023454

9 May 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AHAnn-Kathrin Harsch
Ann-Kathrin Harsch
AKAlexander Kunert
Alexander Kunert
DKDaniel Koska
Daniel Koska
CMChristian Maiwald
Christian Maiwald
The aim of the present study was to determine the effectiveness of nonlinear parameters in distinguishing individual workload in cycling by using bike-integrated sensor data. The investigation focused on two nonlinear parameters: The ML1, which analyzes the geometric median in phase space, and the maximum Lyapunov exponent as nonlinear measure of local system stability. We investigated two hypothesis: 1. ML1α, derived from kinematic crank data, is as good as ML1F, derived from force crank data, at distinguishing between individual load levels. 2. Increasing load during cycling leads to decreasing local system stability evidenced by linearly increasing maximal Lyapunov exponents generated from kinematic data. A maximal incremental cycling step test was conducted on an ergometer, generating complete datasets from 10 participants in a laboratory setting. Pedaling torque and kinematic data of the crank were recorded. ML1F, ML1α, and Lyapunov parameters (λst, λlt, ιst, ιlt) were calculated for each participant at comparable load levels. The results showed a significant linear increase in ML1α across three individual load levels, with a lower but still large effect compared to ML1F. The contrast analysis also confirmed a linearly increasing trend for λst across three load levels, but this was not confirmed for λlt. However, the intercepts ιst and ιlt of the short- and longterm divergence showed a statistically significant linear increase across the load levels. In summary, nonlinear parameters seem fundamentally suitable to distinguish individual load levels in cycling. It is concluded that higher load during cycling is associated with decreasing local system stability. These findings may aid in developing improved e-bike propulsion algorithms. Further research is needed to determine the impact of factors occurring in field application.

13 September 2024 in JMIR Preprints
Verified
Preprint
Open access
TMTobias A Mayer
Tobias A Mayer
DKDaniel Koska
Daniel Koska
AHAnn-Kathrin Harsch
Ann-Kathrin Harsch
CMChristian Maiwald
Christian Maiwald
BACKGROUND Disorders of the patella are among the most prevalent knee injuries. While exercise therapy is widely accepted as an effective treatment strategy, the positive effects of conventional exercise therapy under the guidance of a physiotherapist may be offset by inherent limitations, such as difficulties in scheduling appointments or statutory policies restricting the number of training sessions. Home-based exercise interventions using digital health applications (DHAs) may help address some of these limitations. OBJECTIVE This study aimed to assess the efficacy of a 12-week exercise intervention using a web-based DHA for improving knee function and reducing pain in patients with disorders of the patella (International Classification of Diseases code M22). METHODS The outcomes of the DHA intervention group (IG) were compared to a control group (CG) that received conventional physiotherapy covered by statutory health insurance in Germany (SHI-PT). A total of 259 patients with diagnosed disorders of the patella were included in the trial and randomly allocated to IG DHA (n=136, 52.5%) and CG SHI-PT (n=123, 47.5%). Two primary end points were examined: “knee function” (Knee Injury and Osteoarthritis Outcome Score—Activities of Daily Living [KOOSADL] subscale, range 0-100 points) and “knee pain” (visual analog scale [VAS], range 0-100 points). Participants were asked to complete 2 surveys: one before the first therapy session (PRE) and one after completing the treatment period of 12 weeks (POST). RESULTS Training with the DHA resulted in a 4.5-fold greater improvement in “knee function” (PRE–POST differences in KOOSADL score; IG DHA: 15.7 points, 95% CI 13.7-17.6 vs CG SHI-PT: 3.5 points, 95% CI 1.5-5.5) and a 3.5-fold greater reduction in “knee pain” (PRE–POST differences in VAS pain score; IG DHA: –22.5 points, 95% CI –25.2 to –19.9 vs CG SHI-PT: –6.5 points, 95% CI –8.7 to –4.4) compared to SHI-PT. The improvements in IG DHA exceeded the limits of clinical relevance. The differences between the treatment groups (KOOSADL score –10.1 points, 95% CI –infinity to -8.0; VAS pain score 14.3 points 95% CI 11.7-infinity) were statistically significant (P<.001) for both end points in favor of IG DHA. No effect was found for age or sex. The reported use of pain medication decreased substantially in IG DHA, and showed almost no change in CG SHI-PT. CONCLUSIONS Our findings indicated that the investigated DHA is superior to SHI-PT for treating disorders of the patella. Therefore, DHA has been approved by the German Federal Institute for Drugs and Medical Devices for treating disorders of the patella in persons of all sexes aged ≥12 years. CLINICALTRIAL German Clinical Trials Register (DRKS) DRKS00023454; https://drks.de/search/en/trial/DRKS00023454